Risk & Resolve
In this episode of Risk & Resolve, it breaks down the exploding cost of GLP-1 medications and why many organizations are spending millions on diabetes care—with little improvement in health outcomes. Featuring leaders from American Senior Communities and Northwind, this conversation explores a bold, mandatory program that combines medication, coaching, and accountability to drive real health improvements. From behavior change to data-driven strategy, this episode challenges the “medication-first” mindset and reveals what it actually takes to reverse chronic conditions at scale. Main Talking Points * The wake-up question: Are we spending millions on medications while employees remain sick? * Why diabetes medication costs can be 10x higher than any other condition category * The decision to carve out diabetes care and implement a mandatory, managed program * How Northwind’s model removes barriers: cost, access, complexity, and fragmentation * The power of combining medication + health coaching + accountability * Why “mandatory” can actually be the most compassionate approach to employee health * The reality of behavior change: why people resist—and how to move them anyway * Key KPIs that matter: engagement, risk reduction, GLP-1 utilization, and cost per patient * Results that matter: improved A1Cs, reduced high-risk populations, and lower overall spend * The hidden dangers of GLP-1 overuse and “set-it-and-forget-it” prescribing * Why medication alone is insufficient—and often just masks the problem * The long-term risk: how today’s solutions could create future health and cost issues * Communication strategy at scale: reaching a fragmented workforce effectively * Real-world impact: helping patients move toward remission—not just management * Why sustainable health requires behavior change—not just prescriptions
51 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de Risk & Resolve!